Literature DB >> 30964165

MiR-335 suppresses cell proliferation and migration by upregulating CRKL in bladder cancer.

X-K Liu1, D Chen, X Li.   

Abstract

OBJECTIVE: microRNAs (miRNAs) abnormal expression was proved to regulate the bladder cancer (BC) development. Here, we aimed to investigate the role of miR-335 played in BC.
MATERIALS AND METHODS: Real-time quantitative polymerase chain reaction (RT-qPCR) and Western blot were used to examine the miR-335 and CRKL (CT10 regulator of kinase-like protein) expression level in BC. Methyl thiazolyl tetrazolium (MTT) and RT-qPCR were used to examine cell viability of BC cells. Cell transwell assay was used to assess the migratory ability of BC cells. The direct target of miR-335 in BC was verified by luciferase reporter assay.
RESULTS: The results showed that the expression of miR-335 and CRKL in normal and adjacent tissues showed no significant differences. Whereas, miR-335 expression in BC was significantly lower and CRKL expression was observably higher than normal. CRKL was verified as a specific target of miR-335 in BC cells and the relationship between CRKL and miR-335 expression was negatively correlated in BC tissues. Furthermore, CRKL siRNA group in BC cells remarkably inhibited cell proliferation and migration. MiR-335 mimic in BC cells remarkably curbed cell proliferation and migration and CRKL could reverse the proliferative and migratory ability of BC cells regulated by miR-335.
CONCLUSIONS: miR-335 could suppress BC cell proliferation and migration by upregulating of CRKL.

Entities:  

Year:  2019        PMID: 30964165     DOI: 10.26355/eurrev_201903_17386

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  Linc-ROR has a Potential ceRNA Activity for OCT4A by Sequestering miR-335-5p in the HEK293T Cell Line.

Authors:  Elham Taheri Bajgan; Akram Gholipour; Mohammadali Faghihi; Seyed Javad Mowla; Mahshid Malakootian
Journal:  Biochem Genet       Date:  2021-10-20       Impact factor: 1.890

2.  miR-335-5p inhibits TGF-β1-induced epithelial-mesenchymal transition in non-small cell lung cancer via ROCK1.

Authors:  Wenwen Du; Haicheng Tang; Zhe Lei; Jianjie Zhu; Yuanyuan Zeng; Zeyi Liu; Jian-An Huang
Journal:  Respir Res       Date:  2019-10-21

3.  miR-744-5p Inhibits Multiple Myeloma Proliferation, Epithelial Mesenchymal Transformation and Glycolysis by Targeting SOX12/Wnt/β-Catenin Signaling.

Authors:  Bingling Guo; Chunyan Xiao; Yumin Liu; Ning Zhang; Hao Bai; Tao Yang; Ying Xiang; Yingyu Nan; Qiying Li; Wenjun Zhang; Dehong Huang
Journal:  Onco Targets Ther       Date:  2021-02-22       Impact factor: 4.147

4.  Expression of NANOG and Its Regulation in Oral Squamous Cell Carcinoma.

Authors:  Gašper Grubelnik; Emanuela Boštjančič; Aleš Grošelj; Nina Zidar
Journal:  Biomed Res Int       Date:  2020-07-17       Impact factor: 3.411

5.  Correlation of microRNA-335 expression level with clinical significance and prognosis in non-small cell lung cancer.

Authors:  Wen Huo; Man Zhang; Chunhua Li; Xinying Wang; Xiuli Zhang; Xiaona Yang; Haitao Fei
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

6.  Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling.

Authors:  Jiang Yu; Wen-Xu Chen; Wen-Jing Xie; Rong-Wei Chen; Dan-Qi Lin; Wei-Wei You; Wei-Lin Ye; Hong-Qin Zhang; Dong-Hong Lin; Jian-Ping Xu
Journal:  J Clin Lab Anal       Date:  2021-06-11       Impact factor: 2.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.